Palmitoylethanolamide and Sleep Quality: What Pain-Sleep Research Suggests
Explore how PEA (palmitoylethanolamide) may support sleep quality by reducing pain and neuroinflammation. Evidence-based, honest review.
Explore how PEA (palmitoylethanolamide) may support sleep quality by reducing pain and neuroinflammation. Evidence-based, honest review.
Learn how PEA activates the PPAR-α nuclear receptor to reduce inflammation and pain—what the science shows and what it means for supplementation.
How palmitoylethanolamide (PEA) may support knee osteoarthritis pain without NSAID risks—mechanism, clinical evidence, and honest caveats.
An evidence-based review of human RCTs on palmitoylethanolamide (PEA) for neuropathic pain — mechanism, clinical findings, formulations, and safety.
PEA is an endogenous fatty acid amide studied for neuroinflammation and pain in multiple sclerosis. Here is what current evidence shows.
Palmitoylethanolamide (PEA) is being studied for migraine prevention. Here’s an honest look at the proposed mechanism and early clinical findings.
Explore the clinical evidence on palmitoylethanolamide (PEA) for long COVID symptoms including brain fog, olfactory loss, fatigue, and post-viral pain.
Explore how PEA may reduce IBS gut pain through mast cell stabilization and PPAR-α activation. Evidence-based overview with cited research.
A review of clinical trial evidence on palmitoylethanolamide (PEA) for fibromyalgia pain, sleep, and disability — with honest caveats on what we know so far.
Can PEA reduce pelvic and menstrual pain in endometriosis? We review clinical trials on palmitoylethanolamide endometriosis pain, mechanisms, and evidence limit
Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide that your body produces on demand in response to inflammation, pain
Can PEA help diabetic neuropathy pain? Review clinical evidence, proposed mechanisms, and safety considerations for palmitoylethanolamide supplementation.